- Novel Insights into the Biology of CLL
- Log in to Wiley Online Library
- Advances in Chronic Lymphocytic Leukemia
- Advances in Chronic Lymphocytic Leukemia | Sami Malek | Springer
Get access to the full version of this article. View access options below. You previously purchased this article through ReadCube. Institutional Login. Log in to Wiley Online Library. Purchase Instant Access. View Preview. Learn more Check out.
Novel Insights into the Biology of CLL
Abstract Richter's syndrome RS is the development of an aggressive lymphoma in patients with chronic lymphocytic leukaemia CLL. Citing Literature. Volume 15 , Issue 2 June Pages Related Information. Close Figure Viewer. Browse All Figures Return to Figure.
Log in to Wiley Online Library
Previous Figure Next Figure. Email or Customer ID. Forgot your password? Forgot password?
Advances in Chronic Lymphocytic Leukemia
Old Password. New Password. Password Changed Successfully Your password has been changed. Returning user. Request Username Can't sign in?
- Search Tips.
- Creating a Masterpiece;
- Related Articles!
- Management et sciences cognitives: « Que sais-je ? » n° 3711 (French Edition).
- The Emigrant or Reflections While Descending the Ohio.
- John Thornton Meets Miss Hale Mill Owner;
Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Richter Transformation Active malignancy requiring systemic therapy, other than CLL, with the exception of: adequately treated in situ carcinoma of the cervix uteri; adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin; previous malignancy confined and surgically resected or treated with other modalities with curative intent. Subjects who are positive for hepatitis B core antibody, hepatitis B surface antigen, or hepatitis C antibody must have a negative polymerase chain reaction PCR result before enrollment.
Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Advances in Chronic Lymphocytic Leukemia | Sami Malek | Springer
Please refer to this study by its ClinicalTrials. Layout table for location contacts Contact: Philip A. Thompson, MBBS pathompson2 mdanderson.
- Molecular biomarkers in chronic lymphocytic leukemia. - Abstract - Europe PMC?
- Inherited Genetic Factors!
- Life: Traveling with Gusto: Dons Story!
- Section of Medical Sciences;
- WHY ARE WE FAT??
- On The Wings Of A Song!
Layout table for investigator information Principal Investigator: Philip A. Anderson Cancer Center. More Information. National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Drug: Ibrutinib.
- Loin des châteaux en Espagne (Collection Classique) (French Edition).
- Sodium Intake and Cardiovascular Disease (Annual Review of Public Health Book 32)!
- A Different Point of View!
- Molecular Biomarkers in Chronic Lymphocytic Leukemia - Dimensions;
- Bibliographic Information.
Phase 2. Study Type :.
Estimated Enrollment :. Actual Study Start Date :. Estimated Primary Completion Date :. Estimated Study Completion Date :. Experimental: Ibrutinib Participants take Ibrutinib by mouth 1 time every day for up to 2 years 24 cycles. Accepts Healthy Volunteers:. Contact: Philip A.
Thompson, MBBS. Studies a U. FDA-regulated Drug Product:.